Biogen, a leading biotechnology company, As of 2023, Biogen reported annual revenues of approximately $9.836 billion with about 7500 employees, aimed to enhance its Commercial IT data warehouses to improve data management, reporting capabilities, and overall operational efficiency to support the Asia-Pacific (APAC) region and the US business unit.

Alkermes is a global biopharmaceutical company dedicated to developing innovative medicines for psychiatric and neurological disorders. Founded in 1987, Alkermes leverages its deep expertise in neuroscience to create treatments for complex and difficult-to-treat conditions.